Literature DB >> 34277871

Pre-Transplantation Serum Parathyroid Hormone Influences the Number of Mobilized CD34+ Hematopoietic Stem Cells in Autologous Hematopoietic Stem Cell Transplantation.

Abdolhamed Kian1, Sayeh Parkhideh1, Haniyeh Ghaffari Nazari1, Maryam Nikoonezhad1, Arsalan Jalili1, Shaghayegh Shahsavan1, Abbas Hajifathali1.   

Abstract

BACKGROUND: Parathyroid hormone (PTH) is a calcium homeostasis regulator and can affect bone marrow niche. PTH leads to the bone marrow stem cell niche expansion as well as the induction of stem cell mobilization from the bone marrow into peripheral blood. In this study, we evaluated the association between pre- transplantation serum PTH levels and the number of circulating CD34+ cells along with the platelets/white blood cells (Plt/WBC) engraftment in patients who underwent autologous Hematopoietic Stem Cell Transplantation.
METHODS: Subjects for the study were 100 patients who received autologous hematopoietic stem cell transplantation (auto-HSCT), retrospectively. Serum levels of PTH, calcium, phosphorus, and alkaline phosphatase were measured before mobilization. Their impacts were measured on the number of mobilized CD34+ hematopoietic stem cells, and Plt/WBC engraftment.
RESULTS: High levels of serum PTH (> 63.10 pg/mL) was significantly associated with higher number of CD34+ cells in peripheral blood after granulocyte- colony stimulating factor (G-CSF)-induced mobilization (p= 0.079*). Serum calcium at low levels were associated with higher number of circulating CD34+ cells post mobilization. Pre- transplantation serum levels of phosphorus and alkaline phosphatase on CD34+ numbers were not statistically significant. Serum Plt/WBC engraftment was not improved in presence of high levels of serum PTH.
CONCLUSION: We suggested that serum PTH levels before transplantation could be influential in raising the number of circulating CD34+ hematopoietic stem cell after mobilization.

Entities:  

Keywords:  Auto-HSCT; CD34+ Cell; Pre- transplant PTH

Year:  2021        PMID: 34277871      PMCID: PMC8279713          DOI: 10.52547/rbmb.10.1.76

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  21 in total

Review 1.  Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients.

Authors:  A L Pecora
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

Review 2.  How I treat patients who mobilize hematopoietic stem cells poorly.

Authors:  L Bik To; Jean-Pierre Levesque; Kirsten E Herbert
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

Review 3.  PTH and stem cells.

Authors:  M Ohishi; E Schipani
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

Review 4.  Targeting the stem cell niche: squeezing blood from bones.

Authors:  K Ballen
Journal:  Bone Marrow Transplant       Date:  2007-04-02       Impact factor: 5.483

Review 5.  Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migration.

Authors:  Bruno C Huber; Ulrich Grabmaier; Stefan Brunner
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

6.  Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Authors:  Karen Ballen; Adam M Mendizabal; Corey Cutler; Ioannis Politikos; Katarzyna Jamieson; Elizabeth J Shpall; Bimalangshu R Dey; Eyal Attar; Steven McAfee; Colleen Delaney; Philip McCarthy; Edward D Ball; Ram Kamble; David Avigan; Richard T Maziarz; Vincent T Ho; John Koreth; Edwin Alyea; Robert Soiffer; John R Wingard; Vicki Boussiotis; Thomas R Spitzer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-02       Impact factor: 5.742

7.  Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.

Authors:  Stefan Brunner; Hans Diogenes Theiss; Alfons Murr; Thomas Negele; Wolfgang-Michael Franz
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

8.  Phase I trial of parathyroid hormone to facilitate stem cell mobilization.

Authors:  Karen K Ballen; Elizabeth J Shpall; David Avigan; Beow Y Yeap; David C Fisher; Kathleen McDermott; Bimalangshu R Dey; Eyal Attar; Steven McAfee; Marina Konopleva; Joseph H Antin; Thomas R Spitzer
Journal:  Biol Blood Marrow Transplant       Date:  2007-04-30       Impact factor: 5.742

9.  PTH expands short-term murine hemopoietic stem cells through T cells.

Authors:  Jau-Yi Li; Jonathan Adams; Laura M Calvi; Timothy F Lane; Richard DiPaolo; M Neale Weitzmann; Roberto Pacifici
Journal:  Blood       Date:  2012-09-05       Impact factor: 22.113

Review 10.  Hematopoietic stem cell transplantation.

Authors:  Eleftheria Hatzimichael; Mark Tuthill
Journal:  Stem Cells Cloning       Date:  2010-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.